Sensex Today | Stock Market Live Updates: Aarti Pharmalabs: Expect EBITDA growth of about 10-12% in FY25 Posted by Able on May 14, 2024 Get link Facebook X Pinterest Email Other Apps Commercialization of Atali project expansion expected in Q4FY25Aim to achieve long-term goal of over 15% annual growth in next 3 years Comments
Comments
Post a Comment